Morning Briefing
Summaries of health policy coverage from major news organizations
Study Suggests 2004 Lawsuit Fueled Big Spending On Epilepsy Drugs
Researchers look at what happened after Pfizer pleaded guilty and paid more than $430 million to settle charges that it had illegally marketed Neurontin for unapproved uses.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
